Extended Depth of Focus Contact Lenses for Presbyopia

Last updated: December 12, 2024
Sponsor: Visioneering Technologies, Inc
Overall Status: Completed

Phase

N/A

Condition

Presbyopia

Treatment

NaturalVue Multifocal

Clinical Study ID

NCT05495971
VTI-2206
  • Ages 45-70
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Suitable and able to wear contact lenses

  • Normal best corrected vision (20/25 or better)

  • Need reading add +2.00 or stronger

Exclusion

Exclusion Criteria:

  • Pre-existing ocular condition that would contraindicating lens wear

Study Design

Total Participants: 24
Treatment Group(s): 1
Primary Treatment: NaturalVue Multifocal
Phase:
Study Start date:
September 06, 2022
Estimated Completion Date:
May 12, 2023

Study Description

This study will develop defocus curves for Baseline best corrected spectacle refraction and then for the EDOF lens used in this study. A comparison of thge depth of focus for each condition will be made.

Connect with a study center

  • VTI

    Alpharetta, Georgia 30009
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.